(Q52547202)

3 May 2018

title

Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy. (English)

1 reference

3 May 2018

author name string

Annemieke Aartsma-Rus

1

1 reference

3 May 2018

Mattie Bremmer-Bout

2

1 reference

3 May 2018

Anneke A M Janson

3

1 reference

3 May 2018

Johan T den Dunnen

4

1 reference

3 May 2018

Gert-Jan B van Ommen

5

1 reference

3 May 2018

Judith C T van Deutekom

6

1 reference

3 May 2018

publication date

1 October 2002

1 reference

3 May 2018

published in

Neuromuscular Disorders

1 reference

3 May 2018

volume

12 Suppl 1

1 reference

3 May 2018

page(s)

S71-7

1 reference

3 May 2018

Dystrophin: the protein product of the Duchenne muscular dystrophy locus

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900086-X

7 January 2021

An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900086-X

7 January 2021

The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900086-X

7 January 2021

Glycoprotein complex anchoring dystrophin to sarcolemma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900086-X

7 January 2021

Membrane organization of the dystrophin-glycoprotein complex

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900086-X

7 January 2021

The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900086-X

7 January 2021

Implications of maturation for viral gene delivery to skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900086-X

7 January 2021

Surveying cis-acting sequences of pre-mRNA by adding antisense 2'-O-methyl oligoribonucleotides to a splicing reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900086-X

7 January 2021

Antisense oligonucleotides as therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900086-X

7 January 2021

Novel mechanisms for antisense-mediated regulation of gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900086-X

7 January 2021

The molecular basis of muscular dystrophy in the mdx mouse: a point mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900086-X

7 January 2021

Modification of splicing in the dystrophin gene in cultured Mdx muscle cells by antisense oligoribonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900086-X

7 January 2021

Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900086-X

7 January 2021

Specific removal of the nonsense mutation from the mdx dystrophin mRNA using antisense oligonucleotides.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900086-X

7 January 2021

Oligonucleotides against a splicing enhancer sequence led to dystrophin production in muscle cells from a Duchenne muscular dystrophy patient.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900086-X

7 January 2021

Induction of exon skipping of the dystrophin transcript in lymphoblastoid cells by transfecting an antisense oligodeoxynucleotide complementary to an exon recognition sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900086-X

7 January 2021

The role of exon sequences in splice site selection.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900086-X

7 January 2021

Polypurine sequences within a downstream exon function as a splicing enhancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900086-X

7 January 2021

Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900086-X

7 January 2021

Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900086-X

7 January 2021

The in vitro cultivation and differentiation capacities of myogenic cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900086-X

7 January 2021

Six novel transcripts that remove a huge intron ranging from 250 to 800 kb are produced by alternative splicing of the 5' region of the dystrophin gene in human skeletal muscle.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900086-X

7 January 2021

Disruption of the splicing enhancer sequence within exon 27 of the dystrophin gene by a nonsense mutation induces partial skipping of the exon and is responsible for Becker muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900086-X

7 January 2021

Expression of human full-length and minidystrophin in transgenic mdx mice: implications for gene therapy of Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900086-X

7 January 2021

Analysis of splicing parameters in the dystrophin gene: relevance for physiological and pathogenetic splicing mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2802%2900086-X

7 January 2021

10.1016/S0960-8966(02)00086-X

Identifiers

DOI

1 reference

3 May 2018

release_por5jomtgrdopj2qkts7sgkn3a

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/por5jomtgrdopj2qkts7sgkn3a

24 November 2022

mapped directly with Wikidata item

1 reference

3 May 2018